Announcements Trials

Browse Landscape

Phase

Phase 3 3 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Myasthenia Gravis 1 Adrenal Insufficiency 1

Interventions

Dexamethasone 13 Bevacizumab 9 Saline Solution 8 Bupivacaine 8 Tobacco Use Cessation Devices 7 Specimen Handling 7 Nivolumab 7 Magnetic Resonance Spectroscopy 7 Lenalidomide 7 Fluorouracil 7 pembrolizumab 6 Rituximab 6 Prednisone 6 Letrozole 6 Cisplatin 6 Carboplatin 6 Sodium Chloride 5 Ropivacaine 5 Propofol 5 Human Papillomavirus Recombinant Vaccine nonavalent 5 trametinib 4 lenvatinib 4 dabrafenib 4 cabozantinib 4 anlotinib 4 Trastuzumab 4 Tamoxifen 4 Standard of Care 4 Paclitaxel 4 Immune Checkpoint Inhibitors 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × ravulizumab × 1 year × Clear all

NCT07221838 2026-04-09

OCTAGON

Alexion Pharmaceuticals, Inc.

Phase 4 Recruiting

Adrenal Insufficiency, Myasthenia Gravis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡